A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61K 38/48 (2006.01) A61K 47/16 (2006.01) A61K 47/18 (2006.01) A61K 47/22 (2006.01) A61K 47/36 (2006.01) A61K 47/42 (2006.01) A61K 9/19 (2006.01)
Patent
CA 2400318
A botulinum toxin pharmaceutical composition free of blood derived albumin, comprising a botulinum toxin, sodium chloride or water and a polysaccharide such as a hydroxyethyl starch and/or an amino acid, the pharmaceutical composition being suitable for therapeutic administration to a human patient. Alternately, the polysaccharide and amino acid can be replaced by recombinant albumin.
L'invention concerne une composition pharmaceutique à base de toxine botulique et exempte d'albumine dérivée du sang, comprenant une toxine de botulinum, du chlorure de sodium ou de l'eau et un polysaccharide tel que l'amidon hydroxyéthylé et/ou un acide aminé. Cette composition pharmaceutique convient à l'administration thérapeutique à un patient. Le polysaccharide et l'acide aminé peuvent éventuellement être remplacés par de l'albumine recombinante.
Allergan Inc.
Gowling Lafleur Henderson Llp
LandOfFree
Botulinum toxin pharmaceutical compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Botulinum toxin pharmaceutical compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Botulinum toxin pharmaceutical compositions will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1526190